392 related articles for article (PubMed ID: 22196945)
1. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.
Coovadia HM; Brown ER; Fowler MG; Chipato T; Moodley D; Manji K; Musoke P; Stranix-Chibanda L; Chetty V; Fawzi W; Nakabiito C; Msweli L; Kisenge R; Guay L; Mwatha A; Lynn DJ; Eshleman SH; Richardson P; George K; Andrew P; Mofenson LM; Zwerski S; Maldonado Y;
Lancet; 2012 Jan; 379(9812):221-8. PubMed ID: 22196945
[TBL] [Abstract][Full Text] [Related]
2. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral interventions for preventing breast milk transmission of HIV.
White AB; Mirjahangir JF; Horvath H; Anglemyer A; Read JS
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD011323. PubMed ID: 25280769
[TBL] [Abstract][Full Text] [Related]
5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.
Fowler MG; Coovadia H; Herron CM; Maldonado Y; Chipato T; Moodley D; Musoke P; Aizire J; Manji K; Stranix-Chibanda L; Fawzi W; Chetty V; Msweli L; Kisenge R; Brown E; Mwatha A; Eshleman SH; Richardson P; Allen M; George K; Andrew P; Zwerski S; Mofenson LM; Jackson JB;
J Acquir Immune Defic Syndr; 2014 Mar; 65(3):366-74. PubMed ID: 24189151
[TBL] [Abstract][Full Text] [Related]
7. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
Jamieson DJ; Chasela CS; Hudgens MG; King CC; Kourtis AP; Kayira D; Hosseinipour MC; Kamwendo DD; Ellington SR; Wiener JB; Fiscus SA; Tegha G; Mofolo IA; Sichali DS; Adair LS; Knight RJ; Martinson F; Kacheche Z; Soko A; Hoffman I; van der Horst C;
Lancet; 2012 Jun; 379(9835):2449-2458. PubMed ID: 22541418
[TBL] [Abstract][Full Text] [Related]
8. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
[TBL] [Abstract][Full Text] [Related]
9. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.
Nagot N; Kankasa C; Tumwine JK; Meda N; Hofmeyr GJ; Vallo R; Mwiya M; Kwagala M; Traore H; Sunday A; Singata M; Siuluta C; Some E; Rutagwera D; Neboua D; Ndeezi G; Jackson D; Maréchal V; Neveu D; Engebretsen IMS; Lombard C; Blanche S; Sommerfelt H; Rekacewicz C; Tylleskär T; Van de Perre P;
Lancet; 2016 Feb; 387(10018):566-573. PubMed ID: 26603917
[TBL] [Abstract][Full Text] [Related]
10. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.
Guay LA; Musoke P; Fleming T; Bagenda D; Allen M; Nakabiito C; Sherman J; Bakaki P; Ducar C; Deseyve M; Emel L; Mirochnick M; Fowler MG; Mofenson L; Miotti P; Dransfield K; Bray D; Mmiro F; Jackson JB
Lancet; 1999 Sep; 354(9181):795-802. PubMed ID: 10485720
[TBL] [Abstract][Full Text] [Related]
11. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.
; Bedri A; Gudetta B; Isehak A; Kumbi S; Lulseged S; Mengistu Y; Bhore AV; Bhosale R; Varadhrajan V; Gupte N; Sastry J; Suryavanshi N; Tripathy S; Mmiro F; Mubiru M; Onyango C; Taylor A; Musoke P; Nakabiito C; Abashawl A; Adamu R; Antelman G; Bollinger RC; Bright P; Chaudhary MA; Coberly J; Guay L; Fowler MG; Gupta A; Hassen E; Jackson JB; Moulton LH; Nayak U; Omer SB; Propper L; Ram M; Rexroad V; Ruff AJ; Shankar A; Zwerski S
Lancet; 2008 Jul; 372(9635):300-13. PubMed ID: 18657709
[TBL] [Abstract][Full Text] [Related]
12. Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial.
Lockman S; Hughes M; Powis K; Ajibola G; Bennett K; Moyo S; van Widenfelt E; Leidner J; McIntosh K; Mazhani L; Makhema J; Essex M; Shapiro R
Lancet Glob Health; 2017 May; 5(5):e491-e500. PubMed ID: 28395844
[TBL] [Abstract][Full Text] [Related]
13. Interventions for preventing late postnatal mother-to-child transmission of HIV.
Horvath T; Madi BC; Iuppa IM; Kennedy GE; Rutherford G; Read JS
Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD006734. PubMed ID: 19160297
[TBL] [Abstract][Full Text] [Related]
14. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
Kumwenda NI; Hoover DR; Mofenson LM; Thigpen MC; Kafulafula G; Li Q; Mipando L; Nkanaunena K; Mebrahtu T; Bulterys M; Fowler MG; Taha TE
N Engl J Med; 2008 Jul; 359(2):119-29. PubMed ID: 18525035
[TBL] [Abstract][Full Text] [Related]
15. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
Jackson JB; Musoke P; Fleming T; Guay LA; Bagenda D; Allen M; Nakabiito C; Sherman J; Bakaki P; Owor M; Ducar C; Deseyve M; Mwatha A; Emel L; Duefield C; Mirochnick M; Fowler MG; Mofenson L; Miotti P; Gigliotti M; Bray D; Mmiro F
Lancet; 2003 Sep; 362(9387):859-68. PubMed ID: 13678973
[TBL] [Abstract][Full Text] [Related]
16. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
Lallemant M; Jourdain G; Le Coeur S; Mary JY; Ngo-Giang-Huong N; Koetsawang S; Kanshana S; McIntosh K; Thaineua V;
N Engl J Med; 2004 Jul; 351(3):217-28. PubMed ID: 15247338
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
18. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of life.
Desmond AC; Moodley D; Conolly CA; Castel SA; Coovadia HM
BMC Pediatr; 2015 Mar; 15():23. PubMed ID: 25885678
[TBL] [Abstract][Full Text] [Related]
20. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Brocklehurst P; Volmink J
Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
